Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and KIT and/or FLT3-ITD mutations: results of the SAL MIDOKIT trial

por Ruhnke, Leo, Röllig, Christoph, Herold, Sylvia, Sauer, Tim, Brandts, Christian H., Steffen, Björn, Schäfer-Eckart, Kerstin, Krause, Stefan W., Hänel, Mathias, Reichle, Albrecht, Scholl, Sebastian, Neubauer, Andreas, Mikesch, Jan-Henrik, Schetelig, Johannes, Stölzel, Friedrich, Kramer, Michael, Haake, Annett, Frimmel, Julia, Krämer, Alwin, Schlenk, Richard, Platzbecker, Uwe, Serve, Hubert, Baldus, Claudia D., Müller-Tidow, Carsten, Aust, Daniela, Bornhäuser, Martin, Ehninger, Gerhard, Thiede, Christian
Publicado 2023